PROGESTIN REGULATION OF CELLULAR PROLIFERATION

被引:580
作者
CLARKE, CL [1 ]
SUTHERLAND, RL [1 ]
机构
[1] ST VINCENTS HOSP, GARVAN INST MED RES, DARLINGHURST, NSW 2010, AUSTRALIA
关键词
D O I
10.1210/edrv-11-2-266
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The control of cellular proliferation is known to involve a delicate balance between the effects of different regulatory molecules including hormones and growth factors which provide, in the immediate environment of the cell, signals to stimulate or inhibit cellular replication (1). The past decade has seen significant progress in the identification and characterization of novel regulatory molecules, generally referred to as growth factors, and definition of their molecular mechanisms of action (2, 3). With the recent emphasis on peptide growth factors it is perhaps less well appreciated that some of the largest physiological changes (both positive and negative) in rates of growth and cell proliferation are mediated by steroid hormones. Recent studies on breast cancer cells (4) and immature rat uterus (5, 6), illustrating estrogenic control of autocrine and paracrine growth factor production, support the view that some of these steroid-induced responses are intimately linked to growth factor-mediated pathways although debate continues as to whether the growth factor response is the cause, or the consequence, of the estrogenic effect on cellular proliferation (7, 8). Generally speaking, the molecular mechanisms by which steroid hormones control proliferation are not well defined, with the most developed knowledge being in the area of estrogen action where a number of recent reviews are available (4, 9–11). © 1990 by The Endocrine Society.
引用
收藏
页码:266 / 301
页数:36
相关论文
共 314 条
[1]   STEROIDAL REGULATION OF OESTRADIOL-17-BETA DEHYDROGENASE-ACTIVITY OF THE HUMAN-BREAST CANCER CELL-LINE MCF-7 [J].
ADAMS, EF ;
COLDHAM, NG ;
JAMES, VHT .
JOURNAL OF ENDOCRINOLOGY, 1988, 118 (01) :149-154
[2]   PROGESTIN INHIBITION OF PROGESTERONE-RECEPTOR GENE-EXPRESSION IN HUMAN-BREAST CANCER-CELLS [J].
ALEXANDER, IE ;
CLARKE, CL ;
SHINE, J ;
SUTHERLAND, RL .
MOLECULAR ENDOCRINOLOGY, 1989, 3 (09) :1377-1386
[3]  
ALEXANDER IE, IN PRESS MOL ENDOCRI
[4]  
ALLEGRA JC, 1979, CANCER RES, V39, P1447
[5]  
ALLEGRA JC, 1985, SEMIN ONCOL, V12, P3
[6]   ORAL-CONTRACEPTIVE USE INFLUENCES RESTING BREAST PROLIFERATION [J].
ANDERSON, TJ ;
BATTERSBY, S ;
KING, RJB ;
MCPHERSON, K ;
GOING, JJ .
HUMAN PATHOLOGY, 1989, 20 (12) :1139-1144
[7]   CELL TURNOVER IN THE RESTING HUMAN-BREAST - INFLUENCE OF PARITY, CONTRACEPTIVE PILL, AGE AND LATERALITY [J].
ANDERSON, TJ ;
FERGUSON, DJP ;
RAAB, GM .
BRITISH JOURNAL OF CANCER, 1982, 46 (03) :376-382
[8]   EFFECT OF HYPOPHYSECTOMY AND HORMONE REPLACEMENT ON HORMONE RECEPTOR LEVELS AND THE GROWTH OF 7,12-DIMETHYLBENZ(A)ANTHRACENE-INDUCED MAMMARY-TUMORS IN THE RAT [J].
ARAFAH, BM ;
MANNI, A ;
PEARSON, OH .
ENDOCRINOLOGY, 1980, 107 (05) :1364-1369
[9]   BLOCKADE OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR INHIBITS TRANSFORMING GROWTH-FACTOR ALPHA-INDUCED BUT NOT ESTROGEN-INDUCED GROWTH OF HORMONE-DEPENDENT HUMAN-BREAST CANCER [J].
ARTEAGA, CL ;
CORONADO, E ;
OSBORNE, CK .
MOLECULAR ENDOCRINOLOGY, 1988, 2 (11) :1064-1069
[10]   CONTROL OF HORMONE RECEPTOR LEVELS AND GROWTH OF 7,12-DIMETHYLBENZ(A)ANTHRACENE-INDUCED MAMMARY-TUMORS BY ESTROGENS, PROGESTERONE AND PROLACTIN [J].
ASSELIN, J ;
KELLY, PA ;
CARON, MG ;
LABRIE, F .
ENDOCRINOLOGY, 1977, 101 (03) :666-671